尿液曲霉胞外囊泡半乳呋喃糖抗原检测:曲霉病新诊断的生物学基础
研究开发了基于新型单克隆抗体的尿液检测方法 MycoMEIA-Aspergillus,用于辅助诊断侵袭性曲霉病。抗原主要定位于曲霉胞外囊泡(EVs)上或其内。
要点
- MycoMEIA 尿液检测可检出游离及 EV 相关的含 Galf 聚糖,辅助诊断侵袭性曲霉病。
- mAb476 与 GM 特异性单抗联合使用可优化各样本的检测性能。
- 该检测的受试者水平灵敏度为 91.2%、特异度为 89.2%,尚需设计锁定后的进一步分析确认。
核心结论
- 新型尿液检测可检出游离及 EV 相关的含 Galf 聚糖,从而实现侵袭性曲霉病的尿液检测。
- 仍需对设计锁定后的检测方法开展进一步分析,以确认结果。
研究设计与样本
- 研究用 Galf 特异性单抗筛查侵袭性曲霉病患者的尿液样本,以优化检测设计。
- 用合成的 Galf 寡聚体表征单抗的表位特异性。
- 用免疫沉淀结合质谱及免疫金透射电镜(ITEM)表征 mAb476 识别的抗原。
- 检测性能通过来自 310 人的 920 份尿液样本确定。
主要发现
- 将识别 N-聚糖的 mAb476 与 GM 特异性单抗联用,可优化各样本的检测性能。
- 侵袭性曲霉病患者的尿液中含有多种 mAb476 反应性曲霉蛋白,主要定位于曲霉胞外囊泡上或其内。
- 受试者水平灵敏度为 91.2%(95% CI 76%-98%),特异度为 89.2%(95% CI 82%-94%),检测性能与诊断一致。
关键数值与推荐
- 受试者水平灵敏度 91.2%(95% CI 76%-98%)。
- 受试者水平特异度 89.2%(95% CI 82%-94%)。
临床怎么用
- 该尿液检测有望作为侵袭性曲霉病诊断的辅助手段,可检出游离及 EV 相关的含 Galf 聚糖。
- mAb476 与 GM 特异性单抗联用可作为优化检测组合的策略。
局限性
- 目前仅报告了设计阶段的结果,尚需对设计锁定后的检测方法开展进一步分析确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Establishing diagnosis of pulmonary infections caused by Aspergillus spp., invasive aspergillosis (IA), is difficult. We developed a urinary assay (MycoMEIA-Aspergillus) that deploys novel monoclonal antibodies (mAbs). We describe the biology of urinary antigens and performance as an aid to diagnose IA. METHODS: Urine samples from people with IA were screened with β-D-galactofuranose (Galf)-specific mAbs for optimal design. Epitope specificity of mAbs was characterized using synthesized Galf-oligomers. Antigens recognized by Galf-specific mAb476 were characterized by immunoprecipitation followed by mass spectrometry and immunogold transmission electron microscopy (ITEM). Assay performance was determined with 920 urine samples from 310 people. RESULTS: Combining N-glycan-recognizing mAb476 with a galactomannan (GM)-specific mAb optimized performance across samples. Urine samples from people with IA contained multiple mAb476-reactive Aspergillus proteins, with prominent localization on or within Aspergillus extracellular vesicles (EVs). MycoMEIA receiver operating characteristic curves demonstrated area under curve of 0.97 (95% CI .93-1, P < .0001). Per-subject sensitivity was 91.2% (95% CI 76%-98%) and specificity was 89.2% (95% CI 82%-94%), with performance aligned diagnosis. CONCLUSIONS: The new diagnostic assay detects free and EV-associated Galf-containing glycans enabling urine testing for IA. Further analyses of the design-locked assay are needed for confirmation.
引用
- Datta K, Baburina I, Zhang SX, et al. Detection of Galactofuranose-Containing Antigens Associated With Aspergillus Extracellular Vesicles in Urine: The Biological Basis of a New Diagnostic for Aspergillosis. J Infect Dis. 2026. PMID: 42578816. doi:10.1093/infdis/jiag360
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。